Get started
SAREPTA THERAPEUTICS, INCSAREPTA THERAPEUTICS, INCSAREPTA THERAPEUTICS, INC

SAREPTA THERAPEUTICS, INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Bonds

SRPT chart


Full chart

SRPT upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪69.75 B‬ MXN
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−51.71 MXN
Net income (FY)
‪4.90 B‬ MXN
Revenue (FY)
‪39.66 B‬ MXN
Shares float
‪93.38 M‬
Beta (1Y)
1.26

Employees


Employees (FY)
‪1.37 K‬
Change (1Y)
+58 +4.41%
Revenue / Employee (1Y)
‪28.90 M‬ MXN
Net income / Employee (1Y)
‪3.57 M‬ MXN

About Sarepta Therapeutics, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Douglas S. Ingram
Website
sarepta.com
Headquarters
Cambridge
Founded
1980
FIGI
BBG01RH1NB53
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

SRPT news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

SRPT highest yielding bonds


SRPT5657414
Sarepta Therapeutics, Inc. 1.25% 15-SEP-2027
Yield to maturity
6.20%
Maturity date
Sep 15, 2027

See all SRPT bonds 

Sparks


Curated watchlists where SRPT is featured.

See all sparks 


Check out other big names from the same industry as SRPT.

Frequently Asked Questions


The current price of SRPT is 704.76 MXN — it has decreased by −0.03% in the past 24 hours. Watch SAREPTA THERAPEUTICS, INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange SAREPTA THERAPEUTICS, INC stocks are traded under the ticker SRPT.
SRPT stock has fallen by −40.87% compared to the previous week, the month change is a −67.81% fall, over the last year SAREPTA THERAPEUTICS, INC has showed a −69.89% decrease.
We've gathered analysts' opinions on SAREPTA THERAPEUTICS, INC future price: according to them, SRPT price has a max estimate of 3,595.16 MXN and a min estimate of 777.33 MXN. Watch SRPT chart and read a more detailed SAREPTA THERAPEUTICS, INC stock forecast: see what analysts think of SAREPTA THERAPEUTICS, INC and suggest that you do with its stocks.
SRPT stock is 1.35% volatile and has beta coefficient of 1.26. Track SAREPTA THERAPEUTICS, INC stock price on the chart and check out the list of the most volatile stocks — is SAREPTA THERAPEUTICS, INC there?
Today SAREPTA THERAPEUTICS, INC has the market capitalization of ‪69.75 B‬, it has decreased by −2.35% over the last week.
Yes, you can track SAREPTA THERAPEUTICS, INC financials in yearly and quarterly reports right on TradingView.
SAREPTA THERAPEUTICS, INC is going to release the next earnings report on Jul 30, 2025. Keep track of upcoming events with our Earnings Calendar.
SRPT earnings for the last quarter are −94.24 MXN per share, whereas the estimation was −65.70 MXN resulting in a −43.44% surprise. The estimated earnings for the next quarter are 17.60 MXN per share. See more details about SAREPTA THERAPEUTICS, INC earnings.
SAREPTA THERAPEUTICS, INC revenue for the last quarter amounts to ‪15.26 B‬ MXN, despite the estimated figure of ‪14.08 B‬ MXN. In the next quarter, revenue is expected to reach ‪11.04 B‬ MXN.
SRPT net income for the last quarter is ‪−9.17 B‬ MXN, while the quarter before that showed ‪3.32 B‬ MXN of net income which accounts for −376.48% change. Track more SAREPTA THERAPEUTICS, INC financial stats to get the full picture.
No, SRPT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 19, 2025, the company has ‪1.37 K‬ employees. See our rating of the largest employees — is SAREPTA THERAPEUTICS, INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SAREPTA THERAPEUTICS, INC EBITDA is ‪−1.27 B‬ MXN, and current EBITDA margin is 14.30%. See more stats in SAREPTA THERAPEUTICS, INC financial statements.
Like other stocks, SRPT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SAREPTA THERAPEUTICS, INC stock right from TradingView charts — choose your broker and connect to your account.